Zentalis Pharmaceuticals
ZNTL
$11.06
Share price
0.68%
Change (1 day)
-49.80%
Change (1 year)
Categories
EPS for Zentalis Pharmaceuticals (ZNTL)
EPS in 2023 (TTM): -$4.80
According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.80. In 2022 the company made an earnings per share (EPS) of -$4.53 a decrease over its 2021 EPS that were of -$3.78.
EPS history for Zentalis Pharmaceuticals from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.80 | 5.96% |
| 2022 | -$4.53 | 19.84% |
| 2021 | -$3.78 | 18.48% |
| 2020 | -$3.19 | 47.26% |
| 2019 | -$2.17 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -94.38% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -79.17% | 🇺🇸 USA |